HR Execs on the Move

Oncologix

www.oncologix.biz

 
Oncologix is a diversified medical device and healthcare holding company. For its customers, Oncologix provides FDA approved medical devices and state licensed healthcare services. For its shareholders, Oncologix acquires profitable operations that build, maintain and nourish shareholder value. The Company`s corporate mission is to be the best small cap medical device and healthcare holding company in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.oncologix.biz
  • 3725 Lawrenceville Suwanee Rd Ste b4
    Suwanee, GA USA 30024
  • Phone: 318.769.1958

Executives

Name Title Contact Details

Similar Companies

Emboline, Inc.

Emboline is a medical device company with a game-changing device for total embolic protection during percutaneous heart valve repair and replacement procedures and other cardiovascular procedures with embolic risks.

Healthy Heart Sleep Programs

Healthy Heart Sleep Programs is a Brockton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Medical Equipment Inc

Advanced Medical Equipment Inc is a Dayton, OH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Calibrate

Calibrate is a Carrboro, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LumiThera

At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.